PAVmed Inc. [NASDAQ: PAVM] price surged by 7.79 percent to reach at $0.37. The company report on May 26, 2021 that PAVmed Subsidiary Lucid Diagnostics Receives CE Mark Certification for its EsoCheck® Esophageal Cell Collection Device. Get the hottest stocks to trade every day before the market ope